Osteopenia Diagnosis and Management

Primary Differential Diagnoses

The World Health Organization defines osteopenia as a T-score between -1.0 and -2.5, and this patient's T-score of -1.2 falls within this range, according to the National Comprehensive Cancer Network 1, 2
Postmenopausal status is a primary cause of osteopenia, representing the natural decline in estrogen leading to accelerated bone loss, as stated by the Clinical Infectious Diseases journal 3
Asian ethnicity is an independent risk factor for lower bone density, as noted by the National Comprehensive Cancer Network 2
Multiple risk factors, including a 20 pack-year smoking history, family history of osteoporotic fracture, and postmenopausal status, compound the risk of osteopenia, according to the Clinical Infectious Diseases journal and other sources 3, 4

Hypothyroidism is a significant secondary cause of osteoporosis, and over-replacement with levothyroxine can cause iatrogenic hyperthyroidism, accelerating bone resorption, as stated by the Clinical Infectious Diseases journal 3
Tobacco use is a major modifiable risk factor for bone loss, affecting bone health through multiple mechanisms, including decreased intestinal calcium absorption and increased cortisol levels, according to the Clinical Infectious Diseases journal 3
Vitamin D deficiency is a common and treatable condition that can cause osteomalacia with bone pain and muscle weakness, as noted by the Clinical Infectious Diseases journal 3

Evaluation for secondary causes of osteopenia is necessary, as the prevalence ranges from 44-90% in postmenopausal women, according to the Clinical Infectious Diseases journal 3
Laboratory tests, including vitamin D level, serum calcium and phosphorus, parathyroid hormone, thyroid function tests, complete blood count, and comprehensive metabolic panel, are essential for ruling out metabolic bone disease and other conditions, as stated by the Clinical Infectious Diseases journal 3

The 10-year fracture risk should be calculated using the WHO FRAX tool, which incorporates age, sex, BMI, smoking status, family history of hip fracture, and femoral neck BMD, according to the National Comprehensive Cancer Network and the Clinical Infectious Diseases journal 2, 3
Treatment is recommended if the 10-year risk of major osteoporotic fracture is ≥20% or hip fracture risk is ≥3%, as stated by the Clinical Infectious Diseases journal and other sources 3, 4